0000950170-24-043756.txt : 20240411 0000950170-24-043756.hdr.sgml : 20240411 20240411165358 ACCESSION NUMBER: 0000950170-24-043756 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20240410 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240411 DATE AS OF CHANGE: 20240411 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Talis Biomedical Corp CENTRAL INDEX KEY: 0001584751 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40047 FILM NUMBER: 24839119 BUSINESS ADDRESS: STREET 1: 1100 ISLAND DRIVE STREET 2: SUITE 101 CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: 650-433-3000 MAIL ADDRESS: STREET 1: 1100 ISLAND DRIVE STREET 2: SUITE 101 CITY: REDWOOD CITY STATE: CA ZIP: 94065 FORMER COMPANY: FORMER CONFORMED NAME: SlipChip Corp DATE OF NAME CHANGE: 20130820 8-K 1 tlis-20240410.htm 8-K 8-K
false0001584751Talis Biomedical Corp00015847512024-04-102024-04-10

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 11, 2024 (April 10, 2024)

 

 

Talis Biomedical Corporation

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-40047

46-3122255

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

1375 West Fulton Market

Suite 700

 

Chicago, Illinois

 

60607

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (650) 433-3000

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, $0.0001 par value per share

 

TLIS

 

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On April 10, 2024, Talis Biomedical Corporation (the “Company”) entered into a retention agreement (the “Retention Agreement”) with Rebecca Markovich, Interim Chief Financial Officer. Under the terms of the Retention Agreement, Ms. Markovich is eligible to receive $89,250 if she maintains satisfactory job performance and remains employed with the Company through the completion of a sale, merger or liquidation and dissolution of the Company. The Company intends to file a copy of the Retention Agreement as an exhibit to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2024.

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit Number

Description

 

 

104

Cover Page Interactive Data File (Embedded within the Inline XBRL document)

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

 

 

 

 

Date:

April 11, 2024

By:

/s/ Robert J. Kelley

 

 

 

Robert J. Kelley
Chief Executive Officer

 

 EX-101.SCH 2 tlis-20240410.xsd XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT 100000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink Document Information Document Information [Table] Pre-commencement Issuer Tender Offer Address Type [Domain] Entity Address, State or Province Trading Symbol Soliciting Material Entity Address, City or Town Written Communications Entity Central Index Key CIK Entity Tax Identification Number Entity Registrant Name Registrant Name Former Address [Member] Entity Ex Transition Period Document Period End Date Period End Date Entity Address, Postal Zip Code Entity Incorporation, State or Country Code Local Phone Number City Area Code Document Information [Line Items] Document Information: Pre-commencement Tender Offer Cover [Abstract] Cover Security Exchange Name Entity Emerging Growth Company Amendment Flag Amendment Securities Act File Number Entity Addresses, Address Type [Axis] Entity Address, Address Line Two Entity Address, Address Line One Title of 12(b) Security Document Type Document Type XML 4 R1.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Document And Entity Information
Apr. 10, 2024
Document Information [Line Items]  
Document Type 8-K
Amendment Flag false
Document Period End Date Apr. 10, 2024
Entity Registrant Name Talis Biomedical Corp
Entity Central Index Key 0001584751
Entity Emerging Growth Company true
Securities Act File Number 001-40047
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 46-3122255
Entity Address, Address Line One 1375 West Fulton Market
Entity Address, Address Line Two Suite 700
Entity Address, City or Town Chicago
Entity Address, State or Province IL
Entity Address, Postal Zip Code 60607
City Area Code (650)
Local Phone Number 433-3000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Ex Transition Period false
Title of 12(b) Security Common Stock, $0.0001 par value per share
Trading Symbol TLIS
Security Exchange Name NASDAQ
EXCEL 5 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 6 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 7 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 9 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.u1 html 1 24 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document And Entity Information Sheet http://talisbio.com/20240410/taxonomy/role/Role_DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName - tlis-20240410.htm 8 tlis-20240410.htm tlis-20240410.xsd http://xbrl.sec.gov/dei/2023 false false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "tlis-20240410.htm": { "nsprefix": "tlis", "nsuri": "http://talisbio.com/20240410", "dts": { "inline": { "local": [ "tlis-20240410.htm" ] }, "schema": { "local": [ "tlis-20240410.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "keyStandard": 24, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 3, "http://xbrl.sec.gov/dei/2023": 3 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 30, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 24 }, "report": { "R1": { "role": "http://talisbio.com/20240410/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_e6ca9099-4b9e-4331-b31d-ac9594d8f623", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "tlis-20240410.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_e6ca9099-4b9e-4331-b31d-ac9594d8f623", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "tlis-20240410.htm", "first": true, "unique": true } } }, "tag": { "dei_AddressTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AddressTypeDomain", "presentation": [ "http://talisbio.com/20240410/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Address Type [Domain]", "documentation": "An entity may have several addresses for different purposes and this domain represents all such types." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://talisbio.com/20240410/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "terseLabel": "Amendment", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://talisbio.com/20240410/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "terseLabel": "Cover", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://talisbio.com/20240410/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "terseLabel": "Document Information:", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "presentation": [ "http://talisbio.com/20240410/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Information", "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://talisbio.com/20240410/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://talisbio.com/20240410/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://talisbio.com/20240410/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://talisbio.com/20240410/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://talisbio.com/20240410/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://talisbio.com/20240410/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://talisbio.com/20240410/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityAddressesAddressTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressesAddressTypeAxis", "presentation": [ "http://talisbio.com/20240410/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Addresses, Address Type [Axis]", "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://talisbio.com/20240410/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "CIK", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://talisbio.com/20240410/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://talisbio.com/20240410/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r9" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://talisbio.com/20240410/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Securities Act File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://talisbio.com/20240410/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://talisbio.com/20240410/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://talisbio.com/20240410/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_FormerAddressMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "FormerAddressMember", "presentation": [ "http://talisbio.com/20240410/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Former Address [Member]", "documentation": "Former address for entity" } } }, "auth_ref": [ "r6", "r7" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://talisbio.com/20240410/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://talisbio.com/20240410/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://talisbio.com/20240410/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://talisbio.com/20240410/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://talisbio.com/20240410/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://talisbio.com/20240410/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://talisbio.com/20240410/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://talisbio.com/20240410/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r8" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "249", "Section": "308", "Subsection": "a" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 8-K", "Number": "249", "Section": "308" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 13 0000950170-24-043756-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-24-043756-xbrl.zip M4$L#!!0 ( +R&BUA^4*\@]A( ^@ 1 =&QI?:(/\A$02IEPF MEQ]_.NJV.YV?_G'XP\%?,$;'GSJGZ%1R21/XV$!8^6-,.TW$<95Y^U, M,/4].F:%0"V#&!8F%J;DPB MPVX1VO \0O^'D!8A,\W2P3B3E[T"[88?D&H% M8R>)B.,Q^B03EH22Q:A;#[H'LPP;Z"B.T;EJE:-SD8OL2O!&V6>O '0 2I+\ MX\[,S*_-1II=-JGO^\V1JK-35FJ-@BSF7I,DI+'PFP\7->)$UB_% -*$B3LJ:DUGE:U<#,,5NL\A8DD=IUM%+&)QZ.%?#YKEO^K+OBB8 M9GDL_AS*JX\[[30I0!#@"T# #@K+3Q]W"C$JFIJ1FJK39M7K09#R,!27UL14&$F<],S"S&W- R M7-_R=U#"^FH4(5M'(."X$G*?8G99@38JSD4$0/]'."'SB0_]!+[ EFE2U2W' M+/1MW^)>Y"C*+%?CXPXL7RN2(\%QQ&+@TT/]YZ Y-\W%LQ:A<-R(V)C: 0S$ MPPA[@D98"%-$U+8$(\'LK$\26*QQ&Z:=L;B3<#'Z58R?-?M# IQI>Y9KTT?- M-."V<"WJ8M>S0VR%?HB91QR8N&MZ8>2:-J.W9WHN+F6N2+?(RDRI*=ZD.8<:FH\3A#7G&'P)LB!F_*@+Q/<$TK7MTC#EHF2"9-Z@[I6 MD&;0 R[20&;4+0& MF<#7&1O<'/O>X6"L:\F+'HB3 E?2%@;Y^X_4(?L'3346P#^8A_YNX.R&:S\T MY-T0AC"XR&["&*9QFK5JQ-X-\76Y:D$:\UD4>,]$P6^GG8N38]2].+HXZ1X$ M6?.P>]+^[;QST3GIHJ/38W3R1_N?1Z>_G*#VV9, W0O6?SLZ_H$44_(2^=Q;K<\<*7<>.+&R[!-13%'D8 MW >!N6]X'B.1"VKK>6;1U :H_4AM/6X$0K6]6Y'330-BRX8K9D-_P[CPN7(; M],SYR>D%.C_Y>G9^L6X\.%![4S'Q=9CE0S#F49&BK@AUQ(>:*,T0M7?Y!Y1& MJ.@)533,9"&ASY-1V&/)I5!1)U5,?=.Z@<&"*5-MWI13L"@O$8A"E6+P"=-A MY67MES.CA#2 )ZH&@)"8#7+1RL6 96")EKXE])[575_)7 8R!DNX5=>N*D$M M/F&BNO._[6OG%@K!][[95V63ZI5>B/UKF!8.,L&^M?1OK+Y8P, WAZ_ZJ&4**HX1%T]S2!-"=M8&C#]QPZ\P,S60M9WD5K.I((%',N M5.@ [=:?!0.'0N0%$E,#A&]R'47JJ&>9LC,< M)A;)&O%;88N4V'I *ZYK$A]F9 'P&9]C./BKF/^Y^OBIKL]WH)'?M[>[:G-C M.I1A/6QDS[9446$L1[@,2+4>%SU;K8Y_<,IWH7]AN"W-=-AYLBCS?QZ]1.9F M681NXT&:N0-)NRECJK#G(CEJ#L0H0K <203U"ERU.XQ4%'9A^5] MC*>:U%N9ML$R;1,-7V-J]RZPBN\IN[^A=T^A15_8U 8DJ'7XN -VVJN;W7>* MN,46:V1;GD\$QP9Q+&Q%/L&,"P/;KF=$G!.+V7Q9B[7#N1,+,K-\+">N-2"^N"5 MN"ZV_!!<$@J_&(\LS"*;4!ZPB)K1:I;ZDXP%C!V(;(W+1@C%%B&6^][7S>:N M:;B&@\'V8]BR#!,S,S2Q([R F%2X$6&K6;<+-NI4NWVA9M.U+Z+E8),:AF'; M3UC%>Z2ZNZE"O30-5T\RZUB472V=513NK.B)#/UKF,D<;'=ML:L],+!0YZ3Y M0J][5;SVIC#73OM]F:OL.:2$("H9:(N?&C^=\RXZZ0_B="PR34KS\@:=IHU[ M0SBS+/].XJ0/+L!".!_M&+P5W;>%=@OM%MJG63M;'U8;R)9@PC(L&QN1H9(> MP4H.P,3%GG =PB-B46/I79?20#[B/!-Y7OWY+!-!UZ@MJ>G:Z'>U-?5I&!>@ M';^P[)LH'F$IO_:*T, *(I_[.+(#\-(X"[''#!>'MO#,B!';8"N**MQ>$6.- M*](=0FOD$O)4GW/"7L8FL]?F2JY52*H%H=K7YA-.7<]T7 /DE1EABYKPG^%0 MS.U 4-=D=NBM5G*UX=^S["*]7F= K=T#S%^FK[0%O#>7X'9'*,P'-+FFP#RP M 9$^!;P[G&*;"M]P' X_QDKQKCWJL^QKEEY)?5SE]<*=G3B622KSMQPV>_16 MR[J-RW)RFRA:F,F96=LM^HW*3?77FYI*#?LI/."_I]34:;K/WW_T#.KN MY^A"Q&+02Y-Z"T$?58^'"F'H"+"L>:KU3%OZKGD\PG(. A:ZEN=CTU2QEM!T M,?,C$]L!& A69/D^#98U*Y23HF!@#+8' WP-FR^ MER;J#4MK_91FP/#H5.>U9JCZ6'D,>TA&*I5&=T%A%=FO# MW";MKP(K#T#X6/):#MYV3X3?]'DP-AADZ2"3*DLE2$"<*=%8LJ#MB]A^O M47U[?0K5;AB.>4^VLF\U7--=1\;R[1G=T*U]R7DL'JE>G=6(C#N\"N)1YC,# M3%Z;8\N*;,R$Z6,6A5;D&Z;+++JL\?M[)@L@)I6A-4RJ?*/\=B ^2-,X8,#3 M!4B6I\NYN^G7=RUK_YE!]PU8N!7@H%H!6,?9)4"#F4/ YT-@:,NP*SE[X_"O M.O.[2UW4_G2.#),TH.*CL\7>/Q.%ONE'P@*N<1T'6\SPL>\Z/J;"MFW/< W/ M7WK3O0N64 B+D5Q^ F:6Q::ZB%A A>) 'N114 /^0X. M?"W" T%,P#[EIZ7_AK)I0.4O=^Z;M, ME&6:G461R+:L](*L!,N PYEU>% K48MC8S?X\#C&*NMN66N:I.<0QS:Y@XEE M,FQ%;H!]2D-L.(09H>*N:.G31S=8JY/G0Y%M&>RM,)@):ZSN[7T,@U5UM[N* M:P#.?X$;@YX+_XPW4$9E1";X'"U-[A'2PKJ*T@#]M-Y ]-V\[USS?:>EJ?W, MAI;],J&'Q^4[W(R^&I/HZ^NF6*UCATP??[I05R67MQ"%/13&+,]7DSER-R;1 MCY'^(>9WDZ7WO9'61<841LIK3<=]J+N[JORK+5U]QW2E">JTNJ-&2RQ1&VB@ M<*%O^&:JE5_<]WFSQP \R_,,1Y@X](T06SX),3.HAQW/#%UUU9.Q?%)-93B- MJ1%HI;,Z0U^Y7+#\W2(-O^VAOP+F":$(S"%TQ>*A0 -U[7COC5^PL5$R9P-) M.+)#(PP<@HD?$6S1P,"^YPC,7!O\M0 (U0R7)>%*K94:;77T>_&YT]V2YOLE M39/S@%-]/-1RL.4PH##'L3 +S- 0/@]L:JY*NM8!B_)UBIO1)J4MGWN^YT[J M!>_VE.6<_5E*X.J0*/K\N;W^W+N'+_[=Q$223J(N(E2Y(V,4ZJ02F.8WL%^$ MON[D1L:'S!%,4 #N+M6^RV667A<]% M&V\J1V6)J[]?C\Y.[J"9!R[@?VBXNR[@IR$Q"8FPZ0@0408_CU382>Z1W[M@=1:* SEK*\LR*QL29<WN M\= GV#68KY*5 NPSYH'E:YM1Z$241DN;NA6CC2XF""VO^]Y8+GMPL^OEY[7T MPG^S7K_&ITOU;3W']=Y@7,AK7H^A: M&.2*@FGR1E#& M,I)_Q9MGG4+TD=T@!CI6VU6%>JP5!.>Q7J( +4"S_'$I>KH+J'D17_59Q#675;P-=S Q2'C7(%4R1N@"2 MP5"#\3V(41ZDLL]&/1E(;=C,]#TY#OKOH;[Q/1[7SY>H"R;500=*\+^UD:5: M_5G60J4Q!L@&1)O5\R5OR]][7R+7;Q#:F'V 6EWV4HI"15LGY=J_N@Q\UY;0 MRY"Z>K2J7L[O:357=1+GH>R:N;-WNN_E3KNZ]Z3&>.8&7(OPV&WGZ:YSW7YR MNP$M+=Y57Z+PHCO/%4]5ER&L9^?^G:/P6.1A)@=SS^ZL[H;EY]+Q0E1O1.+$ MJVVA/8'ZWL(>X@:D?&PND2VQ\4>)];[H;:D4%( +?667HO19P4]4WN0Q*UAY M#__N">@-SBNW4";:7>HDL4P$^N/G\\^(5Z\J;A/*WSUP[S5,^:04__(.B(W- M\N_\]A'D;#:_G.LZ^A5QNO?TY!,J<1$P?L?F_MVC/C@_C,0K9 M4.VSZ0R \H5;-4P +AL #05I@L!CA2]Z+([45J#J2)_#J2KT1":&*M*HNP// MJY=F "Z_&;/8Q%,5SGWG'ZS["N\K>BWK MOYY[LV7^+4-L87W'L&Y 3&,]DG.=3CIXXZ*UR6ICG'I:;>1/&# !*]*\&^E7$L1B_:2FVB2I@"^L6UE>#=0GA<$LP+)TE MJZJW9 &S#>][$DI$MQX%6;B1^]T%VSVU# Q[D !$ !T;&ES+3(P,C0P-#$P+GAS9.U= M6V_;.!9^[Z_@>EY:["B^I+<830;9I%T8DUZ0I-C!%(-"EFA'&%GT4'+B_/LE M)5+6A:0=_E&O V#@(-<+ MIJ>=[S?6^S%AW]9%KC\-/H"OL '<.Y$WCV\]$+'1^$"0_#RYO,K M\,=_KJ_ C7,'9S:X1,YB!H,(6. NBN;#;O?AX>'(G7A!B/Q%1)H+CQPTZP++ M8L(O,+3I?7!I1Q ,![W!:ZOWVNKW;@>]X>#-L#05H+=)V$$#??P2?O, .',_VP0UO]%V T\[3)/(]KUP[*%8 =IB[W6?$&='$?;& MBPA^0GAV"2?VPH]..XO@GP4I/_&@2[CU(24E5R#SF'1&$ [="%O1XQR&:8.4 MNN48^T<(3[OD<9<^IBT/K-ZQ==SG-6&PF W26FD-4K#7A\'?8E5(^>,N?3RV M0\B++T)K:MOSM,;$#L=Q:?: @CE.N8)>7M\0.D=3=-\E#W(%Z4,W$G'3>]-- M'F:+>@K 9 A'9%BE@)(L6O67U!Z3+CXBP#@A*8U,!M[L="-Y/&X%(.WE3$+R3:.MO9.T*>W6M M%D/9^*$7%KU0MED:=6LW6O5JQ[^':Q$MFAB>IKSP5>M"/PKY'245XC=U!<$. M A3%[=);_.9\[@43E-PA]^A(&6+DPUNB"J 7WZ]'ZEF)W%VB ,T>N[1X]YK\ M^,G7'_[_>>!^#"(O>AR1QO L1M$!'IG&UB_.,7*4+B3+F1?KT^_1?V2QRZQ[ MZ241!A)I("/N0[K,N*].U?9_, MN[&$.PPGZ\\7OV1JTK?DM!.25\)G,](.D)%KNL"BP'*3I7U#G%(YNE&CF>T% MVX/.B=&#.6["FL'9&.)- 8MD:$%[1X1B9S&&5DK2AI@5DM3(.6S-LVE6*6I+ M6EQDC/[)@M0Z^?88^G1N8J4I6(4!$NL2FV)P2FWS5;-HP M'6)J8Z%QJC/.THBW;K@?H-PPLT(PB<>"LS M"L,%Q+>4+/QU,EF]2QG(E55J@G[NNF09#>EB=9F;I3)8RV5J I>\!JSY&[+2 MPZ_X&T;W7K+3*.)4%J\)\BVVJ:/@YG$V1KX 8_YY3:#(3M]SB.$23#\34C#9 M_ N0"0HUT)NC1?J"[0@ M\]"C$K>Z5DT*4"^1_^T.!5 Z5Y6*U 2-KH?G&-H2$G./:WZ%,H8YV5? 401G MHG536;P96_Y)5GP#]OL%NB@L<#QW.W=V,(62A5)8 MK-YUB"R#4V+Q_A>CA^B.=.7<#N2VDKAT71LU,L#<.%#FVU/1)BWWO%86/WF^ M?#8L%6EB881A9@][OO1$DT]%A29@L__H'#BH0IPKVS#8_A/ ]NN>E/J#\2WU MM4J^0_W% /)@?$4= ?B2BM_:%R*&ZH XMY,IF_@E@J0!APN3KU MR3D?-U2 R0")$)UHRP[)#2&O! $NJ;91LW)2[FC 4(%TO%"1.K40^C WU(') M GEA^ON@X-S8,!!+ T2<\?BS*_+%Z'?]>"7^V>UX)T)!7BI(Q.K7)^_# MW4Z-E2Q A9D./CMV:H0N\$QO2'LBB<^;X$RPWF[@?%R"E4"02*S# MELZYL[(7>Z@WY'UD,@$1"B@4O7KHG3:;Z=43G3& MDF8-:%>PZ.??4)M8#(CEU+"P9:, &P*.+5 J0SO#JGC 3K?V5"J(Q6I=(':I M3Y6[95BCHT*#BZ(NWT0N/K+I"T%E@!]W(: "M*Z?1=$=S;=P#-1 M@,NJR806!GRVM.:82)#(!$RH5O=;-C*TJ>N-RP!4B+%HLP,\%:1_G*RB6]L- M< ^&-(T04'FU;7)E$:^=6)R0V)QYMRT579_3-AL5VY$)S=6);8;;!]2$+GT= MNGP-M$ZIQ>#:IOYG6A>@">@/7HY? 2ZU#K.-#N!MS4XJPU2L0I-R3<#G.!\6 MM;'#FV9)'XK6>5J(@XCY-X^LA#16?8+1K.(S?]XR6B,:*(N?UJ' NGD"7)&U MXH%-*B3-'N :B$-_34)>)Z> HZ^,_S6IB##3@",O1_J:A"K//^!X);$^8P9* M.2M!.$8*T;XFX2MS%3AX>9"O>>8E&0QYWD41LN:A5^0UY%50!"XY:%F9KG6YX9D>=<$F5J4@%EOD31-BM'9YKG7I5%(9SNRQ&: MYI58*[&%565G*/945[G0A4'[ MJO5W5";MI829'.FX*;G]&[7G%?D=J44O<_\W/T4JLSX*RZPT M#HMEN4"Y)N MN4L.].89+V>(Y&DN.-";!UR5-R(T!\0N=&.4$663"/4H.:56ZYU/E5J3U[;_Y, JV,*,L"-G,QDX.E!!I^U MM!G;2TQX>\5H66R_9?8X?N&7Q*BYE'NYI_U-;61Y1EW78[<7_. M;4SD66'GT+WUG-F9)-@>N*G.C!6UOUD.\,>8ZA_( Q)QTW! MF=C2HOSPC-$S.'1ZQ(Y4QL[QIVX5? M%AKB#!W\MD,=D^(TM=L/11R,D_0L=R%/(2D??>.T'+QY78X E5:%73M+!&]+5 5].56M02P/,W E[\/9T.;#-J3EX0[H0 M6.>\'+SE+([MI)3@5\XB*>4XNG'B!5\AR*B09 ML;L:>R5WKG[H\M?!07@L:'_L% MGZL.K0?F:2UQZNK0_M@\[<7>8AW*OS95^9(?6H?V;TS57N+@UL'!6U,YR/K, M=2C^SE3%*SSR.KAX;RH74N>^#A9.3&5!&"W08O\8:/PK8A!:*##0!I1&-K00 M8* YJ(Z8:&'!6+-0'(31PH&!UF$^LJ-%:P.MPG+P2(OF!MJ"DMB4%O4-M A% M42\MNAMH :I":EHX,-#^JX[3:7$(&6L&BL)^6A@PT HL1Q.U:&Z@^5<(5FI1 MVT![3QP.74][EDB13Y3@C_F?D2$_QG8(D]L?NLO0'=KSN4>@T5OL1A"@)!'C M[$5R)W3NX,P^^S]02P$"% ,4 " "\AHM8?E"O(/82 /H $0 M @ $ =&QI XML 15 tlis-20240410_htm.xml IDEA: XBRL DOCUMENT 0001584751 2024-04-10 2024-04-10 false 0001584751 Talis Biomedical Corp 8-K 2024-04-10 DE 001-40047 46-3122255 1375 West Fulton Market Suite 700 Chicago IL 60607 (650) 433-3000 false false false false Common Stock, $0.0001 par value per share TLIS NASDAQ true false